Literature DB >> 14510518

Variable susceptibility of the owl monkey (Aotus nancymae) to four serotypes of dengue virus.

Ann M Schiavetta1, Joseph G Harre, Elizabeth Wagner, Monika Simmons, Kanakatte Raviprakash.   

Abstract

The goal of this study was to determine, for each of four dengue serotypes, whether owl monkeys (Aotus nancymae) become viremic and develop antibody responses in patterns similar to those seen in humans and whether any behavioral parameters are reliably associated with immunologic responses. A secondary goal was to investigate effects of chronic blood sampling on hematologic parameters in this genus. We inoculated 20 owl monkeys with 2 x 10(4) plaque-forming units of one of four dengue serotypes. Blood samples ranging from 0.4 to 0.7 ml per animal were taken each day for 12 consecutive days after inoculation, as well as on days 21, 28, and 60 post-inoculation. The total amount of blood taken per monkey was 8.0 ml during the first 12 days and 9.5 ml during the first 30 days of the study (i.e., up to 17% total blood volume per week and up to 20% total blood volume per month). Detailed behavioral assessments of all animals were made twice daily on every day of sample collection. The dengue-1 group were viremic for an average of 3.75 days. Dengue-2, -3, and -4 groups had average viremias of 1.00, 1.25, and 1.33 days, respectively. All animals demonstrated appropriate antibody responses as determined by enzyme-linked immunosorbency assay (ELISA). Animals tolerated repeated phlebotomy well, as all animals remained within clinically normal hematocrit (HCT) reference ranges, and no lasting effects on HCT occurred in any monkey. Final HCT for most animals was greater than 45% (mean final hematocrit, 45%). The maximum decrease in HCT ranged from 3.5 to 19 (mean, 8.9) percentage points. No consistent correlation of any behavioral disease parameters with viremia and antibody status was demonstrated, although overt illness did occur in two animals. Aotus can be an affordable and safe model for testing dengue vaccine efficacy; further testing with higher doses of dengue-2, -3 and -4 viruses is warranted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14510518

Source DB:  PubMed          Journal:  Contemp Top Lab Anim Sci        ISSN: 1060-0558


  8 in total

1.  Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys.

Authors:  Kleber Juvenal Silva Farias; Paula Renata Lima Machado; José Augusto Pereira Carneiro Muniz; Aline Amaral Imbeloni; Benedito Antônio Lopes da Fonseca
Journal:  Viral Immunol       Date:  2015-02-09       Impact factor: 2.257

Review 2.  Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis.

Authors:  Benjamin M Althouse; Anna P Durbin; Kathryn A Hanley; Scott B Halstead; Scott C Weaver; Derek A T Cummings
Journal:  Virology       Date:  2014-02-14       Impact factor: 3.616

3.  Viremia and the magnitude of the immune response upon infection of green monkeys with dengue virus type 2 are strain-dependent.

Authors:  Jorge Martín; Lisset Hermida; Jorge Castro; Yaremis Romero; Jane Cardosa; Gerardo Guillén
Journal:  Curr Microbiol       Date:  2009-09-26       Impact factor: 2.188

Review 4.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

5.  Models of dengue virus infection.

Authors:  Dennis A Bente; Rebeca Rico-Hesse
Journal:  Drug Discov Today Dis Models       Date:  2006

Review 6.  Can non-human primates serve as models for investigating dengue disease pathogenesis?

Authors:  Kristina B Clark; Nattawat Onlamoon; Hui-Mien Hsiao; Guey C Perng; Francois Villinger
Journal:  Front Microbiol       Date:  2013-10-11       Impact factor: 5.640

Review 7.  Utility, limitations, and future of non-human primates for dengue research and vaccine development.

Authors:  Carlos A Sariol; Laura J White
Journal:  Front Immunol       Date:  2014-09-24       Impact factor: 7.561

Review 8.  Pathogen Dose in Animal Models of Hemorrhagic Fever Virus Infections and the Potential Impact on Studies of the Immune Response.

Authors:  Bryce M Warner
Journal:  Pathogens       Date:  2021-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.